Zobrazeno 1 - 10
of 1 845
pro vyhledávání: ''
Autor:
Isao Miyashiro, Haruka Kudo, Satomi Odani, Yoshihiro Kuwabara, Toshitaka Morishima, Kayo Nakata, Takahiro Tabuchi, Shihoko Koyama, Mizuki Kato
Publikováno v:
Cancer Medicine, Vol 11, Iss 2, Pp 507-519 (2022)
Cancer Medicine
Cancer Medicine
Background An increasing number of cancer survivors have developed multiple primaries. This study aims to describe the incidence and risk patterns of metachronous second primary cancers (SPCs) in Osaka, Japan. Methods Data were obtained from the Osak
Autor:
Tam N M Ngo, Jan Mazur, Eugene S. Chung, Huy Gia Vuong, Vien T. Truong, Vy T. Pham, Binh Q Truong, Quoc Bui, Cassady Palmer
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 24, Pp 8838-8845 (2021)
Cancer Medicine, Vol 10, Iss 24, Pp 8838-8845 (2021)
Background The survival outcome for primary cardiac malignant tumors (PMCTs) based on race has yet to be fully elucidated in previously published literature. This study aimed to address the general long‐term outcome and survival rate differences in
Autor:
Jeremy L Grove, Stephanie M. Perkins, Nosayaba Osazuwa-Peters, Kimberly J. Johnson, Justin M. Barnes, A. Srivastava
Publikováno v:
Cancer. 128:624-632
Background Previous studies have described suicidal ideation among survivors of childhood cancer, but small numbers of events limit the understanding of suicide risk. The objectives of this study were to assess whether childhood cancer survivors are
Autor:
Raj Singh, Nicholas G. Zaorsky, Joshua D. Palmer, Daniel M. Trifiletti, H.K. Perlow, Ming Wang, Eric J. Lehrer, Silvia Scoccianti, Vinai Gondi, Paul D. Brown, Pierina Navarria, Joseph Bovi
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:371-384
Purpose Limited evidence is available on the utility of dose-escalated radiation therapy (DE-RT) with or without temozolomide (TMZ) versus standard-of-care radiation therapy (SoC-RT) for patients with newly diagnosed glioblastoma multiforme. We perfo
Autor:
Seppo Koskinen, Nea Malila, Karri Seppä, Emilia Rissanen, Ossi Rahkonen, Tommi Härkänen, Sanna Heikkinen, Heidi Ryynänen, Satu Männistö, Maarit A. Laaksonen, Pekka Jousilahti, Paul Knekt, Johan G. Eriksson, Janne Pitkäniemi, Harri Rissanen
Publikováno v:
International Journal of Cancer. 149:2010-2019
The trends in incidence of lung cancer in never smokers are unclear as well as the significance of risk factors. We studied time trends in the incidence and risk factors of lung cancer in never smokers in Finland in a large, pooled cohort. We pooled
Publikováno v:
Cancer Medicine, Vol 10, Iss 16, Pp 5661-5670 (2021)
Cancer Medicine
Cancer Medicine
Background Epidemiological evidence regarding the link between cancer and atrial fibrillation (AF) are limited and outcomes of metastatic cancer comorbid with AF need to be elucidated. Objective This study aims to evaluate the prevalence, temporal tr
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer
BMC Cancer
Background There are no epidemiological studies describing rare cancers in Western Australia (WA). We aimed to fill this gap by estimating the incidence and five-year survival of rare, less common and common cancers in WA, based on definitions for ra
Publikováno v:
Cancer Causes Control
PURPOSE: We examined the combined influences of race/ethnicity and neighborhood socioeconomic status (SES) on long-term survival among patients with multiple myeloma (MM). METHODS: Data from the 2000–2015 NCI Surveillance, Epidemiology, and End Res
Publikováno v:
Future Oncology. 17:2183-2192
Aim: To investigate the benefit of chemotherapy among early-stage breast cancer patients with 21-gene recurrence scores of 26–30. Methods: We identified 3754 patients in the Surveillance, Epidemiology, and End Results database. Results: 57.6% of th
Autor:
Jim Hofferkamp, Oliver Bucher, James Brierley, Freddie Bray, Sean Kehoe, D. Maxwell Parkin, Marion Piñeros, John Butler, Eileen Morgan, Citadel J Cabasag, Melina Arnold, Isabelle Soerjomataram
Publikováno v:
International Journal of Cancer. 149:1239-1246
Cancer stage at diagnosis is important information for management and treatment of individual patients as well as in epidemiological studies to evaluate effectiveness of health care system in managing cancer patients. Population-based studies to exam